The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia

References

• Caligaris-Cappio F, Ghia P. The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model. Hematol Oncol Clin North Am 2004; 18: 849–862
   PubMed Web of Science ®Google Scholar
• Montillo M, Hamblin T, Hallek M, Montserrat E, Morra E. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica 2005; 90: 391–399
   PubMed Web of Science ®Google Scholar
• Hamblin T J, Davis Z, Gardiner A, Oscier D G, Stevenson F K. Unmutated immunoglobulin VH, genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854
   PubMed Web of Science ®Google Scholar
• Damle R N, Wasil T, Fais F, Ghiotto F, Valetto A, Allen S L, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847
   PubMed Web of Science ®Google Scholar
• Schade U, Bock O, Vornhusen S, Jager A, Busche G, Lehmann U, et al. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70). Hum Pathol 2006; 37: 1153–1161
   PubMed Web of Science ®Google Scholar
• Francis S, Karanth M, Pratt G, Starczynski J, Hooper L, Fegan C, et al. The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia. Cancer 2006; 107: 1023–1033
   PubMed Web of Science ®Google Scholar
• Hamblin T J, Orchard J A, Ibbotson R E, Davis Z, Thomas P W, Stevenson F K, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99: 1023–1029
   PubMed Web of Science ®Google Scholar
• Ghia P, Guida G, Stella S, Gottardi D, Geuna M, Strola G, et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 2003; 101: 1262–1269
   PubMed Web of Science ®Google Scholar
• Durig J, Nuckel H, Cremer M, Fuhrer A, Halfmeyer K, Fandrey J, et al. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 2003; 17: 2426–2434
   PubMed Web of Science ®Google Scholar
• Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764–1775
   PubMed Web of Science ®Google Scholar
• Buhl A M, Jurlander J, Jorgensen F S, Ottesen A M, Cowland J B, Gjerdrum L M, et al. Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia. Blood 2006; 107: 2904–2911
   PubMed Web of Science ®Google Scholar
• Buhl A M, Jurlander J, Geisler C H, Pedersen L B, Andersen M K, Josefsson P, et al. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia. Eur J Haematol 2006; 76: 455–464
   PubMed Web of Science ®Google Scholar
• Smolej L. The prognostic role of CLLU1 in chronic lymphocytic leukaemia. Eur J Eur J Haematol 2006; 77: 177
   PubMed Web of Science ®Google Scholar
• Cheson B D, Bennett J M, Rai K R, Grever M R, Kay N E, Schiffer C A, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am J Hematol 1988; 29: 152–163
   PubMed Web of Science ®Google Scholar
• Binet J -L, Lepoprier M, Dighiero G, Charron D, D'Athis P, Vaugier G, et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977; 40: 855–864
   PubMed Web of Science ®Google Scholar
• Ritgen M, Lange A, Stilgenbauer S, Döhner H, Bretscher C, Bosse H, et al. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia. Blood 2003; 101: 2049–2053
   PubMed Web of Science ®Google Scholar
• Mainou-Fowler T, Dignum H M, Proctor S J, Parhofer K G. The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL). Leuk Lymphoma 2004; 45: 455–462
   PubMed Web of Science ®Google Scholar
• Wiestner A, Rosenwarld A, Barry T S, Wright G, Davis R E, Henrickson S E, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003; 101: 4944–4951
   PubMed Web of Science ®Google Scholar
• Orchard J A, Ibbotson R E, Davis Z, Wiestner A, Rosenwald A, Thomas P W, et al. ZAP-70 expression and prognosis in chronic lymphocytic leukemia. Lancet 2004; 363: 105–111
   PubMed Web of Science ®Google Scholar
• Gábor MéHES. Chromosome Abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia. Pathol Oncol Res 2005; 11: 205–210
   PubMed Web of Science ®Google Scholar
• Dewald G W, Brockman S R, Paternoster S F, Bone N D, O'Fallon J R, Allmer C, et al. Chromosome anomalies detected by fluorescence in situ hybridization: correlation with significant biological features in B-cell chronic lymphocytic leukemia. Br J Haematol 2003; 121: 287–295
   PubMed Web of Science ®Google Scholar
• Doner H, Stilgenbauer S, Doner K, Bentz M, Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 1999; 77: 266–281
   PubMed Web of Science ®Google Scholar
• Glassman A B, Hayes K J. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005; 158: 88–91
   PubMed Web of Science ®Google Scholar